CUSIP: 46138G599
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / NASDAQ BIOTECH
-
Total 13F shares
-
357,412
-
Share change
-
+8,164
-
Total reported value
-
$7,302,315
-
Price per share
-
$20.43
-
Number of holders
-
14
-
Value change
-
+$162,563
-
Number of buys
-
7
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 46138G599?
CUSIP 46138G599 identifies IBBQ - INVESCO EXCH TRADED FD TR II - NASDAQ BIOTECH in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 46138G599:
Institutional Holders of INVESCO EXCH TRADED FD TR II - NASDAQ BIOTECH (IBBQ) as of Q2 2023
As of 30 Jun 2023,
INVESCO EXCH TRADED FD TR II - NASDAQ BIOTECH (IBBQ) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
357,412 shares.
The largest 10 holders included
Mirae Asset Global Investments Co., Ltd., Raymond James Financial Services Advisors, Inc., Tower Research Capital LLC (TRC), PARTNERS CAPITAL INVESTMENT GROUP, LLP, Clarius Group, LLC, BANK OF AMERICA CORP /DE/, LAKE STREET ADVISORS GROUP, LLC, Capital Investment Advisory Services, LLC, Royal Bank of Canada, and UBS Group AG.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.